Relating To Health Insurance.
This bill will amend existing statutes to require health insurance policies, effective January 1, 2026, to include coverage for CGMs along with related supplies for patients diagnosed with diabetes, even if they are not using insulin. By improving access to CGMs, the legislation aims to lower health care costs associated with untreated diabetes complications and to provide equitable health care access to vulnerable populations in the state. Advocates argue that this could lead to a healthier population and reduce the long-term financial burden on health care systems in Hawaii.
House Bill 820 mandates that all health insurers in Hawaii, including Medicaid managed care programs, provide coverage for continuous glucose monitors (CGMs) for individuals diagnosed with diabetes. This legislation is directed towards addressing significant health care disparity issues faced by residents in rural areas who often experience higher rates of chronic diseases like diabetes. The bill aims to enhance diabetes management through technological advancements, allowing for continuous monitoring of blood glucose levels, which can lead to improved health outcomes and lower emergency care needs.
One notable point of contention is the requirement that insurers include coverage for ongoing repairs, replacements, and the maintenance of these devices, which could increase premiums or affect the scope of insurance coverage available to residents. Additionally, critics may raise concerns regarding the financial implications for insurers and the state Medicaid program in light of expanding mandated coverage. Stakeholders will need to balance the cost of expanded coverage with the potential health benefits, particularly for rural residents who often face greater health challenges.